(PRVA) Privia Health - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US74276R1023

PRVA: Technology, Tools, Services, Networks, Medical, Care

Privia Health Group Inc (NASDAQ:PRVA) is a national physician-enablement company based in Arlington, Virginia, founded in 2007. It partners with medical groups, health plans, and health systems to enhance physician practices and patient experiences, rewarding doctors for both in-person and virtual care. Their services include technology tools for workflow optimization, management services to reduce administrative burdens, a single-TIN medical group for better payer negotiations, an accountable care organization (ACO) focused on value-based care, and a network connecting providers with payers and new patients.

The companys business model is designed to support independent providers through technology and data analytics, enabling them to focus on patient care. The single-TIN structure aligns financial incentives, crucial for value-based care. Their ACO model emphasizes improving quality metrics and reducing costs, often participating in programs like Medicare Shared Savings. Additionally, their network facilitates custom contracts, enhancing scalability and access to patient populations.

Financially, Privia Health has a market cap of approximately $2.7 billion. The current P/E ratio is high at 204, but the forward P/E of 34 suggests anticipated growth. The P/B ratio of 4.39 indicates a premium valuation relative to book value, while the P/S ratio of 1.57 reflects reasonable revenue generation relative to market cap. These metrics highlight the companys potential for future performance and its position in the healthcare services sector.

Additional Sources for PRVA Stock

PRVA Stock Overview

Market Cap in USD 2,935m
Sector Healthcare
Industry Health Information Services
GiC Sub-Industry Health Care Services
IPO / Inception 2021-04-28

PRVA Stock Ratings

Growth Rating 0.76
Fundamental 26.9
Dividend Rating 0.0
Rel. Strength 33.6
Analysts 4.57/5
Fair Price Momentum 22.60 USD
Fair Price DCF 19.80 USD

PRVA Dividends

No Dividends Paid

PRVA Growth Ratios

Growth Correlation 3m 1.6%
Growth Correlation 12m 82.4%
Growth Correlation 5y -66.7%
CAGR 5y 0.73%
CAGR/Max DD 5y 0.01
Sharpe Ratio 12m 0.64
Alpha 26.73
Beta 0.775
Volatility 42.35%
Current Volume 845.5k
Average Volume 20d 895k
What is the price of PRVA stocks?
As of April 19, 2025, the stock is trading at USD 23.68 with a total of 845,501 shares traded.
Over the past week, the price has changed by -1.74%, over one month by +0.25%, over three months by +4.18% and over the past year by +32.88%.
Is Privia Health a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Privia Health is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 26.92 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of PRVA as of April 2025 is 22.60. This means that PRVA is currently overvalued and has a potential downside of -4.56%.
Is PRVA a buy, sell or hold?
Privia Health has received a consensus analysts rating of 4.57. Therefor, it is recommend to buy PRVA.
  • Strong Buy: 15
  • Buy: 6
  • Hold: 2
  • Sell: 0
  • Strong Sell: 0
What are the forecast for PRVA stock price target?
According to ValueRays Forecast Model, PRVA Privia Health will be worth about 24.9 in April 2026. The stock is currently trading at 23.68. This means that the stock has a potential upside of +5.11%.
Issuer Forecast Upside
Wallstreet Target Price 29.2 23.5%
Analysts Target Price 26 9.6%
ValueRay Target Price 24.9 5.1%